Machine learning is on the rise. According to Scopus (www2.scopus.com), the number of publications in medicine with machine learning in the title, abstract, or as a keyword during 2016 to 2018 increased from 1658 to 3904. In psychiatry, applications of machine learning are proposed to improve the accuracy of diagnosis and prognosis and determine treatment choice. At the same time, much of this research has given insufficient attention to high-quality methods, clinical applications, and ethical aspects. This is compounded by poor reporting of performative measures and misleading claims about the high accuracy of such approaches. In this issue of JAMA Psychiatry, the article by Gradus and colleagues1 raises important questions about the place of machine learning in research and practice.
Identify all potential conflicts of interest that might be relevant to your comment.
Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued.
Err on the side of full disclosure.
If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response.
Not all submitted comments are published. Please see our commenting policy for details.
Fazel S, O’Reilly L. Machine Learning for Suicide Research–Can It Improve Risk Factor Identification? JAMA Psychiatry. 2020;77(1):13–14. doi:10.1001/jamapsychiatry.2019.2896
Monkeypox Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.